---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-095596"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:45:57.054461+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Standard BioTools Adopts 2024 Change of Control and Severance Plan for Key Executives

## Summary
- Plan provides 12 months base salary and full equity vesting for non-COC termination for COO Kim, CLO Gallagher, CCO Davis, and others.
- For termination during Change of Control Period: 150% lump-sum of base salary plus bonus, 18-month COBRA, and immediate full equity vesting.
- Plan supersedes the 2023 severance plan and covers eight named executives including SVP King, SVP Abou-Sayed, and CHRO Jensen.
- Plan term runs until August 4, 2026; CEO Michael Egholm remains covered under separate 2023 plan.

## SEC filing metadata
- accession: 0001104659-24-095596
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000110465924095596/0001104659-24-095596-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000110465924095596/tm2422827d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-095596
- JSON: https://secwatch.observer/filing/0001104659-24-095596.json
- Plain text: https://secwatch.observer/filing/0001104659-24-095596.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.